PFE Pfizer absorbed a target cut and downgrade from BofA Securities today. Jason Gerberry slashed his price to $26 from $27 moving to hold. The $140B pharma giant held 15 hold ratings showing neutral sentiment.
BMY Bristol-Myers Squibb saw Tim Anderson trim his target to $67 from $68 despite keeping buy. The drugmaker battled weak analyst conviction with just one buy among 27 ratings.
GEV GE Vernova grabbed the biggest target hike. Consensus jumped to $903 from $893 as the $192B power equipment maker held momentum. Just four sell ratings suggested bullish positioning.
AES AES Corporation suffered the sole downgrade. Consensus dropped from nine holds to two sells as the utility faced pressure. Target fell to $15.22 from $15.33.
XOM Exxon Mobil consensus rose to $162 from $161 as oil volatility persisted. NOC Northrop Grumman climbed to $736 from $735 showing defense strength.
META Meta consensus slipped to $857 from $860 despite holding 60 buy ratings. The $2.2T tech giant faced minimal selling pressure.
Healthcare absorbed the sharpest cuts while industrials gained modest ground.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
